130 related articles for article (PubMed ID: 33894556)
1. Immunohistochemical expression and significance of SATB2 protein in colorectal cancer.
Cígerová V; Adamkov M; Drahošová S; Grendár M
Ann Diagn Pathol; 2021 Jun; 52():151731. PubMed ID: 33894556
[TBL] [Abstract][Full Text] [Related]
2. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
3. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.
Zhang YJ; Chen JW; He XS; Zhang HZ; Ling YH; Wen JH; Deng WH; Li P; Yun JP; Xie D; Cai MY
EBioMedicine; 2018 Feb; 28():62-69. PubMed ID: 29396302
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer.
Eberhard J; Gaber A; Wangefjord S; Nodin B; Uhlén M; Ericson Lindquist K; Jirström K
Br J Cancer; 2012 Feb; 106(5):931-8. PubMed ID: 22333599
[TBL] [Abstract][Full Text] [Related]
5. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer.
Tupá V; Drahošová S; Grendár M; Adamkov M
Pathol Res Pract; 2019 Apr; 215(4):705-711. PubMed ID: 30638861
[TBL] [Abstract][Full Text] [Related]
6. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas.
Kim CJ; Baruch-Oren T; Lin F; Fan XS; Yang XJ; Wang HL
J Clin Pathol; 2016 Dec; 69(12):1046-1050. PubMed ID: 27169755
[TBL] [Abstract][Full Text] [Related]
7. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
8. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.
Yang MH; Yu J; Chen N; Wang XY; Liu XY; Wang S; Ding YQ
PLoS One; 2013; 8(12):e85353. PubMed ID: 24386467
[TBL] [Abstract][Full Text] [Related]
9. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
10. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
11. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
Dabir PD; Svanholm H; Christiansen JJ
APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
Wang S; Zhou J; Wang XY; Hao JM; Chen JZ; Zhang XM; Jin H; Liu L; Zhang YF; Liu J; Ding YQ; Li JM
J Pathol; 2009 Sep; 219(1):114-22. PubMed ID: 19557828
[TBL] [Abstract][Full Text] [Related]
13. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
14. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
Schmoeckel E; Kirchner T; Mayr D
Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
[TBL] [Abstract][Full Text] [Related]
15. SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.
Gu J; Wang G; Liu H; Xiong C
Cell Prolif; 2018 Aug; 51(4):e12455. PubMed ID: 29701273
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
17. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
19. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
Magnusson K; de Wit M; Brennan DJ; Johnson LB; McGee SF; Lundberg E; Naicker K; Klinger R; Kampf C; Asplund A; Wester K; Gry M; Bjartell A; Gallagher WM; Rexhepaj E; Kilpinen S; Kallioniemi OP; Belt E; Goos J; Meijer G; Birgisson H; Glimelius B; Borrebaeck CA; Navani S; Uhlén M; O'Connor DP; Jirström K; Pontén F
Am J Surg Pathol; 2011 Jul; 35(7):937-48. PubMed ID: 21677534
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
Lyn J; Wang Y; Wang F; Shen M; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]